Schedule 13G ownership disclosure
Terns Pharmaceuticals Inc
Common Stock · CUSIP: 880881107
Event date: 2024-12-31
- Filing-level shares
- 5,743,482
- Percent of class
- 6.8%
- BlackRock, Inc.
Shares: 5,743,482 · Class: 6.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-25-001540
- Form type
- SCHEDULE 13G/A
- Filer
- BlackRock, Inc.
- CIK
- CIK 2012383
- Filed
- Feb 05, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership